BioCentury
ARTICLE | Clinical News

EG-1962: Additional Phase I/II data

February 22, 2016 8:00 AM UTC

Additional data from the open-label, dose-escalation, North American Phase I/II NEWTON trial in 72 patients who had an aneurysmal subarachnoid hemorrhage (aSAH) showed that the median intensive care u...